BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10468556)

  • 1. Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids.
    Sarafianos SG; Das K; Clark AD; Ding J; Boyer PL; Hughes SH; Arnold E
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10027-32. PubMed ID: 10468556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
    Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.
    Boyer PL; Gao HQ; Clark PK; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2001 Jul; 75(14):6321-8. PubMed ID: 11413298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage.
    Jamburuthugoda VK; Santos-Velazquez JM; Skasko M; Operario DJ; Purohit V; Chugh P; Szymanski EA; Wedekind JE; Bambara RA; Kim B
    J Biol Chem; 2008 Apr; 283(14):9206-16. PubMed ID: 18218633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase.
    Rezende LF; Drosopoulos WC; Prasad VR
    Nucleic Acids Res; 1998 Jun; 26(12):3066-72. PubMed ID: 9611256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
    Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
    J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positively charged side chain at position 154 on the beta8-alphaE loop of HIV-1 RT is required for stable ternary complex formation.
    Sharma B; Kaushik N; Upadhyay A; Tripathi S; Singh K; Pandey VN
    Nucleic Acids Res; 2003 Sep; 31(17):5167-74. PubMed ID: 12930968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase.
    Feng JY; Anderson KS
    Biochemistry; 1999 Jul; 38(29):9440-8. PubMed ID: 10413520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic interplay among the M184I HIV-1 reverse transcriptase mutant, the central polypurine tract, cellular dNTP concentrations and drug sensitivity.
    Van Cor-Hosmer SK; Daddacha W; Kim B
    Virology; 2010 Oct; 406(2):253-60. PubMed ID: 20701944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Active Site Mutation Causes Serious Resistance of HIV Reverse Transcriptase to Lamivudine: Insight from Multiple Molecular Dynamics Simulations.
    Moonsamy S; Bhakat S; Walker RC; Soliman ME
    Cell Biochem Biophys; 2016 Mar; 74(1):35-48. PubMed ID: 26972300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations.
    Xu HT; Asahchop EL; Oliveira M; Quashie PK; Quan Y; Brenner BG; Wainberg MA
    J Virol; 2011 Nov; 85(21):11300-8. PubMed ID: 21849444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine.
    Feng JY; Myrick FT; Margot NA; Mulamba GB; Rimsky L; Borroto-Esoda K; Selmi B; Canard B
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):89-107. PubMed ID: 16440988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase.
    Feng JY; Anderson KS
    Biochemistry; 1999 Jan; 38(1):55-63. PubMed ID: 9890882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.
    Gao L; Hanson MN; Balakrishnan M; Boyer PL; Roques BP; Hughes SH; Kim B; Bambara RA
    J Biol Chem; 2008 Apr; 283(14):9196-205. PubMed ID: 18218634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site.
    Klarmann GJ; Smith RA; Schinazi RF; North TW; Preston BD
    J Biol Chem; 2000 Jan; 275(1):359-66. PubMed ID: 10617626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.
    Krebs R; Immendörfer U; Thrall SH; Wöhrl BM; Goody RS
    Biochemistry; 1997 Aug; 36(33):10292-300. PubMed ID: 9254628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine.
    Yasutake Y; Hattori SI; Tamura N; Matsuda K; Kohgo S; Maeda K; Mitsuya H
    Sci Rep; 2020 Feb; 10(1):3021. PubMed ID: 32080249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating molecular interactions of
    Hung M; Tokarsky EJ; Lagpacan L; Zhang L; Suo Z; Lansdon EB
    Commun Biol; 2019; 2():469. PubMed ID: 31872074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.